Peptides
Mazdutide
Shop Mazdutide on KimeraChems · code GUIDE (10% off)Definition
Mazdutide is a novel dual-incretin research peptide designed to activate GLP-1 and GIP receptors simultaneously. This combined agonism is being studied for its potential in metabolic regulation, body-weight control, and enhanced insulin responsiveness.
Available Formats
- 10mg lyophilized peptide
Mechanism of Action
Mazdutide acts on both glucagon-like peptide-1 (GLP-1) receptors and glucose-dependent insulinotropic polypeptide (GIP) receptors. Research suggests it may: Dual-pathway incretin agonism is an emerging target for metabolic-health research.
- Improve glucose handling in metabolic models
- Reduce caloric intake via appetite-signaling pathways
- Increase insulin sensitivity
- Enhance metabolic rate
- Support lipid-profile improvements
- Modulate energy-balance signaling in the CNS
Areas of Investigation
Mazdutide is commonly studied for
- Obesity and weight-regulation models
- Insulin-sensitivity studies
- Glucose-tolerance mechanisms
- Hepatic and adipose metabolic pathways
- Energy-expenditure research
- Anti-diabetic experimental models
Safety Profile
Reported findings in research settings include
- Nausea
- Temporary appetite suppression
- GI discomfort
- Headache
- Fatigue
- Occasional hypoglycemia in sensitive models
Disclaimer
For educational purposes only. Not for human consumption.